Scribe Therapeutics
Total Awards:
2
Award Value:
$25,714,480
Institution type:
For profit
Short Name:
Scribe Therapeutics
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Preclinical Stage Projects | Maria Mirotsou | A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events | $12,714,480 |
| Preclinical Stage Projects | Brett Staahl | A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe Hypertriglyceridemia | $13,000,000 |
| Total: $25,714,480.00 |
